# Release Readiness Executive Summary

RUN_ID: `20260422T134401Z`

## Verdict

`TRIAL_BACKED_NON_S3_PROGRESS_NOT_READY`

The roadmap documentation can be completed from repo-local evidence, but one expected input filename is missing: `docs/implementation/unified-clinical-wave1-batch1-wo3-20260421/CWP01_KARTE_ORDER_PERSISTENCE_REPORT.md`. The available equivalent CWP-01 evidence is `CWP01_INTEGRATION_GATE_REPORT.md`.

Since the original roadmap package, artifact-free browser chart-open/local persistence/UI clickthrough evidence, RWO-09 non-S3 static/CI evidence, the object-storage-free dev/Trial runtime profile, RWO-06 no-live readiness/transport repair evidence, RUN_ID `20260423T112258Z` RWO-09 release/security gate refresh evidence, RUN_ID `20260423T150257Z` scoped `medicalmodv2` Trial business acceptance, RUN_ID `20260423T180102Z` reviewer submission packet contract hardening, RUN_ID `20260423T180102Z` current-head reviewer support package refresh, RUN_ID `20260423T190300Z` current sanitized reviewer submission packet creation/validation, RUN_ID `20260423T200259Z` canonical runtime-ready smoke safe evidence, RUN_ID `20260423T234155Z` owner next-work GO plus non-live static/contract/safe-browser refresh evidence, RUN_ID `20260424T000139Z` current-head reviewer submission packet refresh, RUN_ID `20260424T010211Z` rollback/stop-policy evidence hardening, RUN_ID `20260424T025733Z` ORCA Trial reachability expansion planning, RUN_ID `20260424T030710Z` RWO-06B endpoint inventory, RUN_ID `20260424T031608Z` RWO-06D prescription/treatment endpoint-specific `medicalmodv2` L3 Trial acceptance, RUN_ID `20260424T040222Z` post-RWO-06D current-head reviewer submission packet refresh, RUN_ID `20260424T044007Z` exhaustive order-item matrix work, RUN_ID `20260424T044803Z` `指導料` class `130` safe-wrapper/v1 Trial rejection evidence, RUN_ID `20260424T050223Z` RWO-06F2 blocker classification plus RWO-06G base-charge v1 Trial rejection evidence, RUN_ID `20260424T052654Z` RWO-06H injection v1 Trial rejection evidence, and RUN_ID `20260424T055036Z` RWO-06I surgery v1 Trial rejection evidence have been added. Owner standing approval is present for the automation to continue Trial-backed non-S3 roadmap work. These improve Trial-backed release-readiness progress, but they do not close `指導料`, base-charge acceptance, injection acceptance, surgery acceptance, tests, radiology, SOAP/disease Trial reachability, fullflow, actual rollback rehearsal/operator acceptance, broad order matrix coverage, or final release GO/NO-GO gates.

## Functional Conclusion

- Prescription input: not release-complete; local/server/component/static evidence plus partial artifact-free browser local persistence evidence.
- Generic order input: not release-complete; local/server/component/static evidence plus partial artifact-free browser local persistence evidence.
- Electronic chart fullflow: `not_run`.
- ORCA live: limited prior Trial `acceptmodv2` `00001` evidence, scoped Phase4 `medicalmodv2` Trial business acceptance in RUN_ID `20260423T150257Z`, and endpoint-specific prescription/treatment `medicalmodv2` L3 Trial business acceptance for target `00001` / Request_Number `01` / class `01` in RUN_ID `20260424T031608Z`.
- Production ORCA readiness: out of scope for this Trial-only roadmap and not claimed.
- S3/object-storage readiness: out of scope for this roadmap and not claimed.

## Main Blockers

1. Full UI click-through browser evidence remains partial for Clinical Wave 1 workflows, especially prescription and representative order editing.
2. Fullflow is missing; scoped `medicalmodv2` acceptance is not a fullflow substitute.
3. `指導料`, base-charge acceptance, injection acceptance, surgery acceptance, tests, radiology, SOAP, and disease CRUD Trial reachability remains missing. RUN_ID `20260424T031608Z` accepted endpoint-specific prescription and representative treatment/generic `medicalmodv2` L3 Trial evidence, but it is not fullflow or broad order matrix coverage. RUN_ID `20260424T044007Z` now lists documents/fees/order classes explicitly, RUN_ID `20260424T044803Z` shows `指導料` class `130` v1 is safely tested but Trial-rejected, RUN_ID `20260424T050223Z` blocks `指導料` v2 pending a business/Trial data decision and records `baseChargeOrder/110` v1 as live `businessRejected`, RUN_ID `20260424T052654Z` records `injectionOrder/310` v1 as live `businessRejected`, and RUN_ID `20260424T055036Z` records `surgeryOrder/500` v1 as live `businessRejected`.
4. Trial-scope runtime startup and `runtime-ready-smoke` now have current non-S3 evidence, and rollback/stop-policy evidence requirements are sanitized, but broader runtime/fullflow and actual rollback rehearsal/operator acceptance are still incomplete.
5. Reviewer submission packet evidence now exists for accepted head `366b18f1117a5276e5128ada3becfdc28aa2d5f5`, but packet completion and rollback policy hardening do not replace missing fullflow or actual rollback rehearsal evidence.
6. Owner standing approval and next-work GO are present, but final release GO/NO-GO is not recorded.
7. Expected CWP-01 filename is missing and should be accepted or corrected by owner review.

## Latest Evidence Markers

- RUN_ID `20260423T010054Z` / `20260423T023456Z`: artifact-free browser local persistence evidence added for selected RWO-02 through RWO-05 workflows.
- RUN_ID `20260423T040145Z`: artifact-free RWO-02 reception-to-Charts chart-open path added; combined safe browser suite passed 5 tests with no retained forbidden artifacts.
- RUN_ID `20260423T050222Z`: artifact-free Charts UI clickthrough added for SOAP S/O local save and insurance disease add; combined safe browser suite passed 6 tests with no retained forbidden artifacts.
- RUN_ID `20260423T220304Z`: artifact-free RWO-04 treatment-order UI create/readback/update/delete path passed; combined safe browser suite passed 8 tests with zero skips and no retained forbidden artifacts.
- RUN_ID `20260423T030122Z`: RWO-09 non-S3 static/CI evidence passed, including web guards, typecheck, safe browser suite, server CI guard scripts, and server-modernized static-analysis verify.
- RUN_ID `20260423T034854Z`: RWO-10/RWO-11 non-claim boundary refreshed. Production ORCA remains `not_applicable_trial_only`; S3/object storage remains `not_applicable_out_of_scope`.
- RUN_ID `20260423T035517Z`: owner standing approval is recorded as present for Trial-backed non-S3 roadmap continuation. Final release GO/NO-GO remains separate and not recorded.
- RUN_ID `20260423T054833Z`: active handoff created for an object-storage-free dev/Trial runtime profile; dummy S3/MinIO remains forbidden and storage readiness remains a non-claim.
- RUN_ID `20260423T060115Z`: object-storage-free dev/Trial runtime profile implemented and focused-test verified.
- RUN_ID `20260423T091324Z`: one approved Phase4 `medicalmodv2` Trial action executed and classified as not business accepted.
- RUN_ID `20260423T110051Z`: no-live repair completed for disabled-storage readiness aggregation, ORCA gateway/config exception mapping, and gateway log sanitization; 23 focused server tests passed.
- RUN_ID `20260423T112258Z`: RWO-09 non-live release/security gate refresh passed after repairing stale ORCA transport missing-facility tests; full web CI, final server static-analysis verify, guard scripts, and 6-test artifact-free safe browser suite passed.
- RUN_ID `20260423T150257Z`: RWO-06 `apiResult=14` root cause classified as stale Phase4 department/physician context; new active payload passed no-live checks and one sanitized live Trial retry was business accepted.
- RUN_ID `20260423T180102Z`: RWO-09/RWO-11 refreshed the current-head reviewer support package for source commit `2eee5777770484a570c777570d4310c8b1b50a20`; review-package regression tests (27), metadata validation, sidecar sha verification, source-scope secret scan, and excluded-path scan all passed.
- RUN_ID `20260423T180102Z`: RWO-11 hardened the canonical reviewer submission packet flow so it copies only allowlisted sanitized closeout files and rejects raw XML / stacktrace / HAR / request XML / raw-network references. Historical closeout `20260414T010624Z` still fails the new contract because `qa/acceptmodv2/accept-summary.sanitized.json` is absent.
- RUN_ID `20260423T190300Z`: RWO-11 created `artifacts/orca-remediation/closeout/20260423T190300Z/` and validated the canonical reviewer submission packet for accepted ref `master` frozen at `5a141e8e9256475904f14ba47ac5d459c4ea421e`; fullflow remained explicitly `not_run`.
- RUN_ID `20260423T200259Z`: RWO-09 repaired `runtime-ready-smoke.mjs` so it no longer writes screenshots, started the canonical `orca-trial-no-object-storage` runtime pair, and passed `runtime-ready-smoke` with JSON-only evidence and zero blocked-route hits.
- RUN_ID `20260423T234155Z`: RWO-09/RWO-11 recorded owner GO for the next roadmap work and passed non-live web guard, typecheck, server guard scripts, review package/packet contract tests, and the 8-test artifact-free browser suite with zero retained forbidden artifacts.
- RUN_ID `20260424T000139Z`: RWO-11 refreshed the current-head reviewer submission packet for accepted ref `master` frozen at `82cfff6db7f7045551eb0d0f9f109ad1afaace07`; packet create/validate, review-packet regression tests, doc links, focused forbidden-pattern scan, focused secret-pattern scan, and `git diff --check` passed.
- RUN_ID `20260424T010211Z`: RWO-09/RWO-11 hardened cutover/release-validation rollback and fullflow evidence requirements to sanitized summaries only, keeping actual rollback rehearsal/operator acceptance and final release GO/NO-GO open.
- RUN_ID `20260424T025733Z`: RWO-06B/RWO-06C/RWO-06D/RWO-08B reachability expansion was added so hourly automation can batch multiple ORCA Trial reachability checks while preserving endpoint-level checkpoints and duplicate live-mutation prevention.
- RUN_ID `20260424T030710Z`: RWO-06B static inventory mapped current prescription/treatment send paths to `medicalmodv2`, kept SOAP/disease as local-only current product paths pending safe wrappers, and created the next active wrapper-prep handoff.
- RUN_ID `20260424T031608Z`: RWO-06D completed endpoint-specific prescription and representative treatment/generic `medicalmodv2` wrapper prep and live Trial checks; both active v2 identities returned `businessAccepted` through sanitized evidence with duplicate-live checkpoint keys.
- RUN_ID `20260424T040222Z`: RWO-11 refreshed and validated the canonical reviewer submission packet for accepted ref `master` frozen at `366b18f1117a5276e5128ada3becfdc28aa2d5f5`; packet create/validate, review-packet regression tests, doc links, retained forbidden-artifact file scan, focused forbidden-text scan, and focused secret-pattern scan passed.
- RUN_ID `20260424T044007Z`: RWO-06E created the exhaustive order-item matrix covering documents, `文書料`, `指導料`, tests, treatments, injections, charges, surgery, radiology, local-only rows, and accepted endpoint-specific identities; live Trial execution was not performed in this matrix task.
- RUN_ID `20260424T055036Z`: RWO-06I added endpoint-specific `surgeryOrder/500` wrapper/payload evidence plus one sanitized Trial attempt; live result was `businessRejected`, not accepted.

## ORCA Connection Scope

This plan connects only to WebORCA / ORCA Trial. Production ORCA connectivity, production ORCA credentials, and production patient data are not required for this roadmap.

## S3 / Object Storage Scope

This plan skips tasks requiring S3, MinIO, attachment-storage S3, PHR export S3, or equivalent object-storage setup.
